​NLSD 2017: An opportunity to evaluate and speed-up new projects – Meet GE Healthcare at the Uppsala BIO booth

On September 13, between 1 and 2 p.m., Stefan Löfås, Science Director for Strategic Technologies at GE Healthcare (GE), will visit Uppsala BIO’s booth at Nordic Life Science Days. This will be an opportunity for scientists, innovators and smaller companies to receive a commercial appraisal of their innovations and ideas, as well as to get advice on how to speed-up the development of their projects.

Representing one of the leading providers of tools for developing and manufacturing biopharmaceuticals, Löfås hopes many people within his field will take the opportunity to stop by the booth and have a chat.

“We are always interested in hearing about new technologies and talking to people working on solutions that could further improve the areas we are involved in,” he says, “from academics working on early research projects to start-ups developing technologies that complement ours, with whom we could collaborate in the future.”

“But of course,” he adds, “anyone with an interest in our field is welcome to stop by: scientists who would like an evaluation of an idea they are thinking about developing, pharmaceutical companies that want to talk about overcoming industrial bottlenecks, or smaller businesses with products already on the market; anyone with an interest in biopharmaceuticals.”

Löfås is attending the Uppsala BIO booth as a part of a collaboration called ‘Industrial Partnerships’. Aimed at helping small companies, innovators and scientists to accelerate the development of their projects, the partnership focuses mainly on finding new technologies and tools that have the potential to significantly improve the process of purifying, analysing and manufacturing biological therapeutics.

A new center for bioprocess innovation in Uppsala
As well as appearing at the Uppsala BIO booth, GE will be present in the Swelife booth to present the new center for bioprocess innovation that will open in Uppsala next year. Partly financed by the Swedish government and located at the GE Healthcare Life Sciences site in Uppsala, the new, fully-equipped facility will allow research groups, start-ups and smaller companies to access infrastructure that would otherwise more difficult.

“Apart from creating an opportunity to bridge the gap between research and development and the industrial production of biopharmaceuticals,” Löfås says, “the center will allow smaller players to access equipment they normally would not be able to afford, thus enabling them to speed-up the development of their projects.”

Currently under construction, the BioProcess Innovation Center is scheduled to open in mid-2018.

Learn more about the other companies taking part in Industrial Partnership and attending NLSDays 2017:

http://nlsdstockholmuppsala.nu/